yidy 3 Champions From the Patch Yielding Over 6%
|
|
Rrmv 2 Top Pharmaceutical Stocks to Buy on the TSX Today
Artificial intelligence AI has made significant strides in recent years and is pervasive in nearly all industries today. Most firms, particularly in the technology sector, say they use the popular technology or have AI tools to attract customers.The upward trajectory of the AI global market appears unstoppable because it pav stanley deutschland es the way for new possibilities and existing opportunities. People in the investment world believe AI stocks are pote stanley us ntial goldmines as wider adoption would lead to enormous profits.If you want to ride on the AI wave and exposure to the space, watch out for Enghouse Systems Limited TSX:ENGH and Tecsys Inc. TSX:TCS . Both companies have AI platforms but with different orientations and target markets.The former provides contact centre technology, while the latter offers practical supply chain AI technologies. Either way, the businesses have solid growth potential and their stocks could deliver massive gains.Turning contact centres into growth e stanley cup nginesMarkham-base Bedm Boost Your TFSA With This Prime Investment
So far, it s been a lacklustre year for IPOs. While there have been some winners like Lightspeed POS TSX SPD , by and large, 2019 has been a boring year for investors craving IPOs. But hold on: things may be about to change.There are four stocks that analysts agree might be heading to market soon. And they stanley cups re all in technology the most promising sector for IPOs since marijuana.In alphabetical order, here are four stocks to watch.HootsuiteHootsuite is one of the world stanley website most widely used platforms for managing social media and boasts over 15 million users. Based in Vancouver, it s latest funding round in March 2018 raised $65 million. The lead investor is CIBC.PointClickCareBased in Mississauga, Ontario, PointClickCare develops web-based products and services to help long-term care providers manage the complete lifecycle of resident care. In its most recent round of funding, which began in February 201 stanley tazas 8, the company raised $186 million. The lead investor is Dragoneer Inve |
|
|
|
|
|
|
|
|
|
|
